• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性脂肪酸酰胺水解酶抑制剂作为新型潜在抗癫痫药物。

Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents.

机构信息

Department of Excellence of Biotechnology, Chemistry and Pharmacy, 2018-2022, University of Siena, Via Aldo Moro 2, 53100 Siena, Italy.

Department of Experimental Medicine Tor Vergata, University of Rome, Via Montpellier 1, 00121 Rome, Italy.

出版信息

ACS Chem Neurosci. 2021 May 5;12(9):1716-1736. doi: 10.1021/acschemneuro.1c00192. Epub 2021 Apr 23.

DOI:10.1021/acschemneuro.1c00192
PMID:33890763
Abstract

Temporal lobe epilepsy is the most common form of epilepsy, and current antiepileptic drugs are ineffective in many patients. The endocannabinoid system has been associated with an on-demand protective response to seizures. Blocking endocannabinoid catabolism would elicit antiepileptic effects, devoid of psychotropic effects. We herein report the discovery of selective anandamide catabolic enzyme fatty acid amide hydrolase (FAAH) inhibitors with promising antiepileptic efficacy, starting from a further investigation of our prototypical inhibitor . When tested in two rodent models of epilepsy, reduced the severity of the pilocarpine-induced status epilepticus and the elongation of the hippocampal maximal dentate activation. Notably, did not affect hippocampal dentate gyrus long-term synaptic plasticity. These data prompted our further endeavor aiming at discovering new antiepileptic agents, developing a new set of FAAH inhibitors (-). Biological studies highlighted and as the best performing analogues to be further investigated. In cell-based studies, using a neuroblastoma cell line, and could reduce the oxinflammation state by decreasing DNA-binding activity of NF-kB p65, devoid of cytotoxic effect. Unwanted cardiac effects were excluded for (Langendorff perfused rat heart). Finally, the new analogue reduced the severity of the pilocarpine-induced status epilepticus as observed for .

摘要

颞叶癫痫是最常见的癫痫类型,目前的抗癫痫药物在许多患者中无效。内源性大麻素系统与癫痫发作的按需保护反应有关。阻断内源性大麻素的分解代谢会产生抗癫痫作用,而没有精神作用。我们在此报告了从我们的原型抑制剂进一步研究开始,发现具有有前景的抗癫痫疗效的选择性花生四烯酸酰胺水解酶(FAAH)抑制剂。当在两种癫痫啮齿动物模型中进行测试时, 减少了匹罗卡品诱导的癫痫持续状态的严重程度和海马最大齿状回激活的延长。值得注意的是, 不影响海马齿状回的长时程突触可塑性。这些数据促使我们进一步努力,旨在发现新的抗癫痫药物,开发一组新的 FAAH 抑制剂(-)。生物学研究突出了 和 作为进一步研究的最佳表现类似物。在基于细胞的研究中,使用神经母细胞瘤细胞系, 和 可以通过降低 NF-kB p65 的 DNA 结合活性来减轻氧化炎症状态,而没有细胞毒性作用。 (Langendorff 灌注大鼠心脏)排除了对心脏的不良影响。最后,新类似物 减少了匹罗卡品诱导的癫痫持续状态的严重程度,如 所观察到的那样。

相似文献

1
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents.选择性脂肪酸酰胺水解酶抑制剂作为新型潜在抗癫痫药物。
ACS Chem Neurosci. 2021 May 5;12(9):1716-1736. doi: 10.1021/acschemneuro.1c00192. Epub 2021 Apr 23.
2
Latest advances in the discovery of fatty acid amide hydrolase inhibitors.脂肪酸酰胺水解酶抑制剂研究的最新进展。
Expert Opin Drug Discov. 2013 May;8(5):509-22. doi: 10.1517/17460441.2013.780021. Epub 2013 Mar 14.
3
Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.小鼠大脑中脂肪酸酰胺水解酶活性及其抑制作用的体外成像
J Pharmacol Exp Ther. 2006 Mar;316(3):1088-97. doi: 10.1124/jpet.105.094748. Epub 2005 Nov 8.
4
Piperidine and piperazine inhibitors of fatty acid amide hydrolase targeting excitotoxic pathology.脂肪酸酰胺水解酶抑制剂哌啶和哌嗪针对兴奋毒性病理学。
Bioorg Med Chem. 2019 Dec 1;27(23):115096. doi: 10.1016/j.bmc.2019.115096. Epub 2019 Sep 10.
5
Inhibition of fatty acid amide hydrolase, a key endocannabinoid metabolizing enzyme, by analogues of ibuprofen and indomethacin.布洛芬和吲哚美辛类似物对脂肪酸酰胺水解酶(一种关键的内源性大麻素代谢酶)的抑制作用。
Eur J Pharmacol. 2007 Jun 22;565(1-3):26-36. doi: 10.1016/j.ejphar.2007.02.051. Epub 2007 Mar 7.
6
Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.内源性大麻素转运体和脂肪酸酰胺水解酶抑制剂的药理学特性
Cell Mol Neurobiol. 2006 Jul-Aug;26(4-6):407-23. doi: 10.1007/s10571-006-9072-6. Epub 2006 May 31.
7
A perspective review on fatty acid amide hydrolase (FAAH) inhibitors as potential therapeutic agents.脂肪酸酰胺水解酶(FAAH)抑制剂作为潜在治疗药物的视角综述。
Eur J Med Chem. 2020 Feb 15;188:111953. doi: 10.1016/j.ejmech.2019.111953. Epub 2019 Dec 30.
8
Anandamide Signaling Augmentation Rescues Amygdala Synaptic Function and Comorbid Emotional Alterations in a Model of Epilepsy.大麻素信号增强可挽救癫痫模型杏仁核突触功能和共病情绪改变。
J Neurosci. 2020 Jul 29;40(31):6068-6081. doi: 10.1523/JNEUROSCI.0068-20.2020. Epub 2020 Jun 29.
9
Elevating endocannabinoid levels: pharmacological strategies and potential therapeutic applications.提高内源性大麻素水平:药理学策略和潜在的治疗应用。
Proc Nutr Soc. 2014 Feb;73(1):96-105. doi: 10.1017/S0029665113003649. Epub 2013 Oct 18.
10
Antiepileptogenic Effect of Subchronic Palmitoylethanolamide Treatment in a Mouse Model of Acute Epilepsy.亚慢性棕榈酰乙醇胺治疗对急性癫痫小鼠模型的抗癫痫发生作用
Front Mol Neurosci. 2018 Mar 14;11:67. doi: 10.3389/fnmol.2018.00067. eCollection 2018.

引用本文的文献

1
Dysregulation of the Cannabinoid System in Childhood Epilepsy: From Mechanisms to Therapy.儿童癫痫中大麻素系统的失调:从机制到治疗
Int J Mol Sci. 2025 Jun 27;26(13):6234. doi: 10.3390/ijms26136234.
2
The State of Synthetic Cannabinoid Medications for the Treatment of Pain.用于治疗疼痛的合成大麻素药物现状
CNS Drugs. 2024 Aug;38(8):597-612. doi: 10.1007/s40263-024-01098-9. Epub 2024 Jul 1.
3
Amyotrophic Lateral Sclerosis and Pain: A Narrative Review from Pain Assessment to Therapy.肌萎缩侧索硬化症与疼痛:从疼痛评估到治疗的叙事性综述。
Behav Neurol. 2024 Mar 16;2024:1228194. doi: 10.1155/2024/1228194. eCollection 2024.
4
rs324420 Polymorphism: Biological Pathways, Impact on Elite Athletic Performance and Insights for Sport Medicine.rs324420 多态性:生物学途径、对精英运动员表现的影响以及运动医学的启示。
Genes (Basel). 2023 Oct 16;14(10):1946. doi: 10.3390/genes14101946.
5
Commonalities for comorbidity: Overlapping features of the endocannabinoid system in depression and epilepsy.共病的共性:抑郁症和癫痫中内源性大麻素系统的重叠特征。
Front Psychiatry. 2022 Oct 19;13:1041460. doi: 10.3389/fpsyt.2022.1041460. eCollection 2022.
6
Polypharmacological Approaches for CNS Diseases: Focus on Endocannabinoid Degradation Inhibition.多靶点药物治疗中枢神经系统疾病的策略:聚焦内源性大麻素降解抑制。
Cells. 2022 Jan 29;11(3):471. doi: 10.3390/cells11030471.